The report surveys the landscape of patent litigation related to Abbreviated New Drug Applications (ANDAs) submitted to the FDA. The report showcases the power of Legal Analytics, examining:
• Top districts
• Top parties and firms
• Filing trends
• ANDA vs. other patent litigation
• Orange book data
• Timing and injunctions
• Damages